Why is Piramal Pharma Ltd ?
1
Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.92 times
- Poor long term growth as Net Sales has grown by an annual rate of 9.22% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.92 times
- The company has been able to generate a Return on Equity (avg) of 0.26% signifying low profitability per unit of shareholders funds
- PBT LESS OI(Q) At Rs 45.70 cr has Grown at 238.6% (vs previous 4Q average)
- NET SALES(Latest six months) At Rs 4,886.98 cr has Grown at 22.87%
- PAT(Q) Highest at Rs 5.58 cr.
2
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 02-Nov-26
- Multiple factors for the stock are Bullish like MACD, KST and OBV
3
With ROCE of 2.4, it has a Expensive valuation with a 2.8 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 26.12%, its profits have risen by 118.1% ; the PEG ratio of the company is 33.4
How much should you hold?
- Overall Portfolio exposure to Piramal Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Piramal Pharma for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Piramal Pharma
26.12%
0.67
39.19%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
9.22%
EBIT Growth (5y)
15.90%
EBIT to Interest (avg)
0.82
Debt to EBITDA (avg)
5.18
Net Debt to Equity (avg)
0.62
Sales to Capital Employed (avg)
0.65
Tax Ratio
100.00%
Dividend Payout Ratio
20.35%
Pledged Shares
0
Institutional Holding
28.09%
ROCE (avg)
2.40%
ROE (avg)
0.26%
Valuation Key Factors 
Factor
Value
P/E Ratio
3945
Industry P/E
40
Price to Book Value
3.90
EV to EBIT
117.82
EV to EBITDA
30.66
EV to Capital Employed
2.79
EV to Sales
3.76
PEG Ratio
33.41
Dividend Yield
NA
ROCE (Latest)
2.37%
ROE (Latest)
0.10%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Movement
10What is working for the Company
PBT LESS OI(Q)
At Rs 45.70 cr has Grown at 238.6% (vs previous 4Q average
NET SALES(Latest six months)
At Rs 4,886.98 cr has Grown at 22.87%
PAT(Q)
Highest at Rs 5.58 cr.
EPS(Q)
Highest at Rs 0.04
-2What is not working for the Company
DEBT-EQUITY RATIO(HY)
Highest at 0.72 times
NON-OPERATING INCOME(Q)
is 44.02 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Piramal Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 45.70 cr has Grown at 238.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs -32.98 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 5.58 cr has Grown at 108.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs -68.13 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Latest six months
At Rs 4,886.98 cr has Grown at 22.87%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 5.58 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 0.04
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Piramal Pharma
Non Operating Income - Quarterly
is 44.02 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
Debt-Equity Ratio - Half Yearly
Highest at 0.72 times
in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio